Richard Bergström
Richard Bergström is co-founder of start-up PharmaCCX and VP of Life Sciences at Guardtime SA. He also serves as a board member of the European Health Forum Gastein (EHFG), which takes place from 2 to 4 October 2019 in Bad Hofgastein, Austria. Among the key topics of the EHFG 2019 are disruptive technologies and the way digital transformation is shaping society, politics and healthcare. Richard previously was the Director General of the European Federation of Pharmaceutical Industries and Associations (EFPIA) from 2011 to 2017. He served for nine years as the Director-General of LIF, the Swedish Association of the Pharmaceutical …
Richard Bergström is co-founder of start-up PharmaCCX and VP of Life Sciences at Guardtime SA.
He also serves as a board member of the European Health Forum Gastein (EHFG), which takes place from 2 to 4 October 2019 in Bad Hofgastein, Austria. Among the key topics of the EHFG 2019 are disruptive technologies and the way digital transformation is shaping society, politics and healthcare.
Richard previously was the Director General of the European Federation of Pharmaceutical Industries and Associations (EFPIA) from 2011 to 2017. He served for nine years as the Director-General of LIF, the Swedish Association of the Pharmaceutical Industry, following positions in Switzerland in regulatory affairs at the pharmaceutical companies Roche and Novartis.
Richard Bergström was also appointed by the Swedish Government to the Board of the Karolinska Institute. He is a pharmacist by training, and received his MScPharm Degree from the University of Uppsala, Sweden in 1988.
See more
He also serves as a board member of the European Health Forum Gastein (EHFG), which takes place from 2 to 4 October 2019 in Bad Hofgastein, Austria. Among the key topics of the EHFG 2019 are disruptive technologies and the way digital transformation is shaping society, politics and healthcare.
Richard previously was the Director General of the European Federation of Pharmaceutical Industries and Associations (EFPIA) from 2011 to 2017. He served for nine years as the Director-General of LIF, the Swedish Association of the Pharmaceutical Industry, following positions in Switzerland in regulatory affairs at the pharmaceutical companies Roche and Novartis.
Richard Bergström was also appointed by the Swedish Government to the Board of the Karolinska Institute. He is a pharmacist by training, and received his MScPharm Degree from the University of Uppsala, Sweden in 1988.
Articles: Richard Bergström
How Big Pharma Succeeds In The Era Of Digital Transformation
Opinion / Much has been made of how Big Pharma needs to learn from Big Tech in order to fully adapt to the digital age. Here, pharma industry veteran Richard Bergström argues that, in fact, the technology industry has much to learn from the pharmaceutical industry and that biopharma is well-placed to take the lead in digital…
Latest Report
